Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions-Reference-Cited by-同舟云学术

Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions

Published:2013-01 Issue:1 Volume:24 Page:61-68
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Ormiston John A.,Charles O’Shaughnessy,Mann Tift,Hall Jack J.,McGarry Thomas,Cannon Louis A.,Webster Mark W.I.,Mishkel Gregory J.,Underwood Paul L.,Dawkins Keith D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review;International Journal of Environmental Research and Public Health;2023-02-07

2. Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions;International Journal of Cardiology;2020-02

3. Two-year results after coronary stenting of small vessels in Japanese population using 2.25-mm diameter sirolimus-eluting stent with bioresorbable polymer: primary and long-term outcomes of CENTURY JSV study;Cardiovascular Intervention and Therapeutics;2018-01-18

4. Long Coronary Lesions Treated With Thin Strut Bioresorbable Polymer Drug Eluting Stent: Experience From Multicentre Randomized CENTURY II Study;Journal of Interventional Cardiology;2016-02

5. Comparison of Long-Term Outcomes in Real-World Patients Between Resolute Zotarilumus-Eluting and Paclitaxel-Eluting Stents in Small Vessel;Angiology;2015-10-18